| Name | Title | Contact Details |
|---|
OncoGenex is a biopharmaceutical company committed to the development and commercialization of new therapies that address treatment resistance in cancer patients. OncoGenex has a diverse oncology pipeline, with each product candidate having a distinct mechanism of action and representing a unique opportunity for cancer drug development. OncoGenex and Teva Pharmaceutical Industries Ltd. have entered a global collaboration and licensing agreement to develop and commercialize OncoGenex' lead drug candidate, custirsen. Custirsen is currently in Phase 3 clinical development as a treatment in men with metastatic castrate-resistant prostate cancer and in patients with advanced, unresectable non-small cell lung cancer. Apatorsen is in Phase 2 clinical development and OGX-225 is currently in pre-clinical development.
Amirsys, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Salt Lake City, UT. To find more information about Amirsys, Inc., please visit www.amirsys.com
BioMedcom Consultants Inc is a Varennes, QC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cedar Community Foundation is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in West Bend, WI. To find more information about Cedar Community Foundation, please visit www.cedarcommunity.org
omnipath diagnostics is a Canoga Park, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.